Lung cancer vaccine: How does it work?

The phase one clinical trial will take place at 34 sites across seven countries. Picture: Aaron Chown/PA Wire

A trial to determine the safety of a novel vaccine for lung cancer will take place at sites across England and Wales.

The first UK patient received the jab at the National Institute for Health Research UCLH Clinical Research Facility on Tuesday.